Mortimer K, Lesosky M, Garcia-Marcos L, et al. The burden of asthma, hay fever and eczema in adults in 17 countries: GAN phase I study. Eur Respir J. 2022. https://doi.org/10.1183/13993003.02865-2021.

Article  PubMed  PubMed Central  Google Scholar 

Asher MI, Rutter CE, Bissell K, et al. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network phase I cross-sectional study. Lancet. 2021;398(10311):1569–80.

Article  PubMed  PubMed Central  Google Scholar 

Dusser D, Montani D, Chanez P, et al. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy. 2007;62(6):591–604.

Article  CAS  PubMed  Google Scholar 

Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394(10196):407–18.

Article  PubMed  Google Scholar 

Chinese TS. Expert consensus on the diagnosis, treatment and management of mild bronchial asthma in China (2023 edition). Zhonghua Jie He He Hu Xi Za Zhi. 2023;46(9):880–96.

Google Scholar 

Ding B, DiBonaventura M, Karlsson N, Ling X. A cross-sectional assessment of the prevalence and burden of mild asthma in urban China using the 2010, 2012, and 2013 China National Health and Wellness Surveys. J Asthma. 2017;54(6):632–43.

Article  PubMed  Google Scholar 

Vignola AM, Chanez P, Campbell AM, et al. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med. 1998;157(2):403–9.

Article  CAS  PubMed  Google Scholar 

Spallarossa D, Battistini E, Silvestri M, et al. Steroid-naive adolescents with mild intermittent allergic asthma have airway hyperresponsiveness and elevated exhaled nitric oxide levels. J Asthma. 2003;40(3):301–10.

Article  CAS  PubMed  Google Scholar 

Mohan A, Lugogo NL, Hanania NA, et al. Questions in mild asthma: an official American Thoracic Society research statement. Am J Respir Crit Care Med. 2023;207(11):e77–96.

Article  PubMed  PubMed Central  Google Scholar 

Mulgirigama A, Barnes N, Fletcher M, Pedersen S, Pizzichini E, Tsiligianni I. A review of the burden and management of mild asthma in adults - implications for clinical practice. Respir Med. 2019;152:97–104.

Article  PubMed  Google Scholar 

FitzGerald JM, Barnes PJ, Chipps BE, et al. The burden of exacerbations in mild asthma: a systematic review. ERJ Open Res. 2020. https://doi.org/10.1183/23120541.00359-2019.

Article  PubMed  PubMed Central  Google Scholar 

Matsunaga K, Hirano T, Oka A, et al. Progression of irreversible airflow limitation in asthma: Correlation with severe exacerbations. J Allergy Clin Immunol Pract. 2015;3(5):759–64.

Article  PubMed  Google Scholar 

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2024. Updated May 2024[EB/OL]. https://ginasthma.org/2024-report/.

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, [2025–05–06]. http://www.ginasthma.org.

Expert Panel Working Group of the National Heart L, Blood Institute a, coordinated National Asthma E, et al. Focused updates to the asthma management guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020;146(6):1217–70.

Article  Google Scholar 

Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF Jr, Pace W, Schatz M. Managing asthma in adolescents and adults: 2020 asthma guideline update from the National Asthma Education and Prevention Program. JAMA. 2020;324(22):2301–17.

Article  PubMed  Google Scholar 

O’Byrne PM, FitzGerald JM, Bateman ED, et al. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med. 2018;378(20):1865–76.

Article  PubMed  Google Scholar 

Hardy J, Baggott C, Fingleton J, et al. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet. 2019;394(10202):919–28.

Article  CAS  PubMed  Google Scholar 

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2019. Updated May 2019[EB/OL]. https://ginasthma.org/reports/2019-gina-report-global-strategy-for-asthma-management-and-prevention/. Accessed 2019-04-12

Bateman ED, Reddel HK, O’Byrne PM, et al. As-needed budesonide-formoterol versus maintenance budesonide in mild asthma. N Engl J Med. 2018;378(20):1877–87.

Article  CAS  PubMed  Google Scholar 

Beasley R, Holliday M, Reddel HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med. 2019;380(21):2020–30.

Article  PubMed  Google Scholar 

Iain Crossingham ST, Ramakrishnan S, et al. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Cochrane Database Syst Rev. 2021;5(5):013518.

Google Scholar 

Iain Crossingham ST, Ramakrishnan S, et al. Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review. BMJ Evid Based Med. 2022;27(3):178–84.

Article  PubMed  Google Scholar 

Wang L, Zhou L, Zheng P, Mao Z, Liu H. Mild asthma is not mild: risk factors and predictive biomarkers for severe acute exacerbations and progression in mild asthma. Expert Rev Respir Med. 2023;17(12):1261–71.

Article  CAS  PubMed  Google Scholar 

Postma DS, Brightling C, Baldi S, et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. Lancet Respir Med. 2019;7(5):402–16.

Article  PubMed  Google Scholar 

Kraft M, Richardson M, Hallmark B, et al. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study. Lancet Respir Med. 2022;10(7):661–8.

Article  CAS  PubMed  Google Scholar 

Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.

Article  CAS  PubMed  Google Scholar 

Miller A, Enright PL. PFT interpretive strategies: American Thoracic Society/ European Respiratory Society 2005 guideline gaps. Respir Care. 2012;57(1):127–33.

Article  PubMed  Google Scholar 

Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–88.

Article  PubMed  PubMed Central  Google Scholar 

Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999 This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):309–29.

Article  CAS  PubMed  Google Scholar 

Coates AL, Wanger J, Cockcroft DW, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017. https://doi.org/10.1183/13993003.01526-2016.

Article  PubMed  Google Scholar 

Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65.

Article  PubMed  Google Scholar 

Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99(5):553–8.

Article  PubMed  Google Scholar 

Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99.

Article  PubMed